References
- Alzoghaibi MA, Al-Mofleh IA, Al-Jebreen AM. (2007). Lipid peroxides in patients with inflammatory bowel disease. Saudi J Gastroenterol 13:187–90
- Amini-Shirazi N, Hoseini A, Ranjbar A, et al. (2009). Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphoraclinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol Mech Methods 19:183–9
- Arafa HM, Hemeida RA, El-Bahrawy Al, Hamada FM. (2009). Prophylactic role of curcumin in dextran sulfate sodium (DSS)-induced ulcerative colitis murine model. Food Chem Toxicol 47:1311–17
- Ardizzone S, Porro GB. (2005). Biologic therapy for inflammatory bowel disease. Drugs 65:2253–86
- Bauerle PA, Henkel T. (1994). Function and activation of NF-κB in the immune system. Ann Rev Immunol 2:141–79
- Berkhout M, Friederich P, Van Krieken JH, et al. (2006). Low detoxification capacity in the ileal pouch mucosa of patients with ulcerative colitis. Inflamm Bowel Dis 12:112–16
- Cho EJ, Shin JS, Noh YS, et al. (2011). Anti-inflammatory effects of methanol extract of Patrinia scabiosaefolia in mice with ulcerative colitis. J Ethnopharmacol 136:428–35
- Coskun M, Olsen J, Seidelin JB, Nielsen OH. (2011). MAP kinases in inflammatory bowel disease. Clin Chim Acta 412:513–20
- Eaden JA, Mayberry JF. (2002). Guidelines for screening surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51:10–12
- Erickson RA, Chang K, Lifrak E, et al. (1992). 16, 16-Dimethyl prostaglandin E2 reduces bile acid-mediated intestinal vascular injury in rats. Gastroenterology 102:1295–305
- Goldstein JL, Silverstein FE, Agrawal NM, et al. (2000). Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol 95:1681–90
- Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–8
- Guruvayoorappan C, Afira AH, Kuttan G. (2006). Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol 17:255–67
- Guruvayoorappan C, Kuttan G. (2007a). Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression and endothelial cell migration and capillary tube formation. J Exp Ther Oncol 6:241–50
- Guruvayoorappan C, Kuttan G. (2007b). Immunomodulatory and antitumour activity of Biophytum sensitivum extract. Asian Pac J Cancer Prev 8:27–32
- Guruvayoorappan C, Kuttan G. (2008). Methanol extract of Biophytum sensitivum alters the cytokine profiles and inhibits iNOS and COX-2 expression in LPS/Con A stimulated macrophages. Drug Chem Toxicol 31:175–88
- Hagar HH, El-Medany A, El-Eter E, Arafa M. (2007). Ameliorative effect of pyrrolidine dithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol 554:69–77
- Itzkowitz SH. (2006). Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am 35:553–71
- Jagtap AG, Shirke SS, Phadke AS. (2004). Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 90:195–204
- Jirovetz L, Buchbauer G, Wobus A, et al. (2004). Medicinally used plants from India: Analysis of the essential oil of air-dried Biophytum sensitivum (L.) DC. Sci Pharm 72:87–96
- Kakkar K, Das P, Viswanathan P. (1984). A modified method for assay of superoxide dismutase. Ind J Biochem Biophys 21:131–2
- Karin M, Greten FR. (2005). NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749–59
- Kruidenier L, Verspaget HW. (2002). Oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous? Aliment Pharmacol Ther 16:1997–2015
- Kundu JK, Surh YJ. (2004). Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat Res 555:65–80
- Kuo MY, Ou HC, Lee WJ, et al. (2011). Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C alpha/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor gamma/nuclear factor-kappaB (PKC-alpha/ERK/PPAR-gamma/NF-kappaB) signaling pathway in endothelial cells. J Agric Food Chem 59:5100–8
- Millar AD, Rampton DS, Chander CL, et al. (1996). Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis. Gut 39:407–15
- Moron MS, Depierre JW, Mannervik B. (1979). Levels of glutathione, glutathione reductase and glutathione-S-transferase activities in rat lung and liver. Biochim Biophys Acta 582:67–78
- Ohkawa H, Ohishi N, Yagi K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–8
- Oktyabrsky ON, Smirnova GV. (2007). Redox regulation of cellular functions. Biochem (Mosc) 72:132–45
- Pratheeshkumar P, Tharakan, JR, Girija Kuttan. (2012). Nomilin inhibits metastasis via induction of apoptosis and regulates the activation of transcription factors and the cytokine profile in B16F-10 cells. Integr Cancer Ther 11:48–60
- Sakthivel KM, Guruvayoorappan C. (2012). Biophytum sensitivum: Ancient medicine, modern targets. J Adv Pharm Technol Res 3:83–91
- Van der Veen BS, de Winther MP, Heeringa P. (2009). Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxid Redox Signal 11:2899–937
- Viera N, Silvia C, Viktor B. (2000). Effect of N-acetylcysteine on colitis induced by acetic acid in rats. Gen Pharmacol 35:77–81
- Wang YH, Ge B, Yang XL, et al. (2011). Proanthocyanidins from grape seeds modulates the nuclear factor-kappa B signal transduction pathways in rats with TNBS-induced recurrent ulcerative colitis. Int Immunopharmacol 11:1620–7
- Xu CT, Meng SY, Pan BR. (2004). Drug therapy for ulcerative colitis. World J Gastroenterol 10:2311–17